Search Results 91-100 of 17157 for monoclonal antibody
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...
... monoclonal antibody;; The relative lack of awareness by patients and providers of the availability of such therapeutic options; and; The fact that such use of ...
The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...
Trastuzumab is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal ...
Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic ...
The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.
The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...
Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...
About this study. The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody (mAb)) may be beneficial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.